RUBICON
Rubicon Research LimitedNSEMarket Closed · NSE · INR
Open
₹1,751
High
₹1,870
Low
₹1,741.9
Prev Close
₹1,748.4
Market Cap
₹28.86 K Cr
Large Cap
P/E (TTM)
98.56
EPS
₹17.74
Div Yield
0.09%
P/B Ratio
23.83
ROE
22.4%
Key Metrics
Analyst Ratings(2 analysts)
Target Price
₹1,898
+2.0% upside
Current price: ₹1,861
What If I Had Invested?
Chart data not available for this range
AI Analysis
Get AI-powered sentiment analysis, strengths, risks, and outlook for this stock.
AI Technical Analysis
Buy/sell zones with live web research
Get AI-generated buy zones, sell targets, stop-loss levels and a technical narrative — powered by AI with live web search for the latest news and analyst moves.
Patterns are measured on real price data, then AI-validated. Pattern detection is free when nothing clean is found.
About
Rubicon Research Limited operates as a specialty pharmaceutical company in India, the United States, and internationally. The company develops products in the areas of analgesics/pain management, cardiovascular system, central nervous system, hypokalemia, skeletal muscle relaxants, nicotine replacem...
Technical Indicators
Quality scores
Valuation bands
Intrinsic value calculators
Peer Comparison
Dividend History
Recent: ₹1.50/shareRecent Filings (NSE)
Raw NSE filings — full text + attachments. Tap any row for an AI summary that explains what it means for the stock.
Institutional Deals(NSE)
Source: NSE India. Block deals ≥5L shares or ≥₹10Cr. Bulk deals ≥0.5% of shares.
Governance Scorecard
AlphaView compositeFund Actions
News
News sourced from RSS feeds. Headlines link to original articles.
Disclaimer: This is AI-generated educational information, not investment advice. Stock data is delayed by up to 15 minutes. Past performance does not guarantee future results. Please consult a SEBI-registered investment advisor before making investment decisions.